股票 › GDRX
好药价 GDRX
美股市值排名 #3098
$3.51 +$0.02 (+0.57%)
休市 · Nov 7, 5:10 am ET · 最新盘后价 $3.54 +0.85%
开盘$3.43
昨收$3.49
当日区间$3.33 – $3.55
成交量1.17M
市值$1.20B
市盈率（TTM）58.5
股息率–
财报
财报日平均波动±12.6%近16次财报
收涨次数8 / 1650% 的概率
最佳反应+20.4%
最差反应-22.5%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 5 Aug 2026 | After Market | – | +13.76% | – |
| 2026/Q1 | 6 May 2026 | After Market | ±14.6% | +10.51% | 符合区间 |
| 2025/Q4 | 25 Feb 2026 | After Market | ±20.4% | -18.78% | 符合区间 |
| 2025/Q3 | 4 Nov 2025 | After Market | ±39.1% | +2.15% | 符合区间 |
| 2025/Q2 | 6 Aug 2025 | After Market | ±19.6% | -20.05% | 超出定价预期 |
| 2025/Q1 | 7 May 2025 | After Market | ±35.1% | +11.87% | 符合区间 |
| 2024/Q4 | 27 Feb 2025 | Pre Market | ±29.8% | +1.84% | 符合区间 |
| 2024/Q3 | 7 Nov 2024 | Pre Market | ±22.1% | -17.51% | 符合区间 |
| 2024/Q2 | 8 Aug 2024 | Pre Market | ±17.9% | -18.58% | 超出定价预期 |
| 2024/Q1 | 9 May 2024 | Pre Market | ±20.1% | -8.94% | 符合区间 |
| 2023/Q4 | 29 Feb 2024 | Pre Market | ±24.6% | +20.40% | 符合区间 |
| 2023/Q3 | 9 Nov 2023 | Pre Market | ±29.9% | -18.83% | 符合区间 |
| 2023/Q2 | 9 Aug 2023 | Pre Market | ±29.5% | -9.15% | 符合区间 |
| 2023/Q1 | 10 May 2023 | Pre Market | ±24.2% | +2.35% | 符合区间 |
| 2022/Q4 | 28 Feb 2023 | After Market | ±19.7% | +3.97% | 符合区间 |
| 2022/Q3 | 8 Nov 2022 | After Market | ±29.7% | -22.52% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$200.41M-1.3% YoY
营业利润$23.63M-11.9% YoY
净利润$8.54M-33.5% YoY
摊薄每股收益$0.02-50.0% YoY
自由现金流$66.42M+112.5% YoY
经营现金流$80.83M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率90.8%
营业利润率9.5%
净利率2.1%
净资产收益率2.5%
资产收益率0.9%
投入资本回报率3.1%
流动比率1.38
负债/资产比率72.4%
现金及投资$296.11M
总负债$533.59M
净现金（净负债）-$237.48M
自由现金流/营收16.8%
暂无评论——快来第一个聊聊 GDRX。
登录后参与讨论。